Synergistic immune responses induced by endogenous retrovirus and herpesvirus antigens result in increased production of inflammatory cytokines in multiple sclerosis patients

Scandinavian Journal of Immunology

Volumn 67, Issue 3, 2008, Pages 295-303

  Brudek, T ^a   Christensen, T ^a   Hansen, H J ^a   Petersen, T ^a   Moller Larsen A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; VIRUS ANTIGEN;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES VIRUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RETROVIRUS; TH1 CELL;

ADULT; ANTIGENS, VIRAL; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; ENDOGENOUS RETROVIRUSES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRIDAE; HUMANS; INFLAMMATION; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; TH1 CELLS; TH2 CELLS;

EID: 38849183413     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02067.x     Document Type: Article

References (51)

1. Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D. Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction. Clin Neurol Neurosurg 2006 108 : 241 4.
2. Fox EJM. Immunopathology of multiple sclerosis. Neurology 2004 63 : S3 7.
3. Brudek T, Christensen T, Hansen HJ, Bobecka J, Moller-Larsen A. Simultaneous presence of endogenous retrovirus and herpes virus antigens has profound effect on cell-mediated immune responses: implications for multiple sclerosis. AIDS Res Hum Retroviruses 2004 20 : 415 23.
4. Ozenci V, Kouwenhoven M, Link H. Cytokines in multiple sclerosis: methodological aspects and pathogenic implications. Mult Scler 2002 8 : 396 404.
5. Ffrench-Constant C. Pathogenesis of multiple sclerosis. Lancet 1994 343 : 271 5.
6. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005 23 : 683 747.
7. Clerici M, Saresella M, Trabattoni D et al. Single-cell analysis of cytokine production shows different immune profiles in multiple sclerosis patients with active or quiescent disease. J Neuroimmunol 2001 121 : 88 101.
8. Wujek JR, Bjartmar C, Richer E et al. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002 61 : 23 32.
9. Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003 206 : 165 71.
10. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000 47 : 707 17.
11. Baranzini SE, Elfstrom C, Chang SY et al. Transcriptional analysis of multiple sclerosis brain lesions reveals a complex pattern of cytokine expression. J Immunol 2000 165 : 6576 82.
12. Frohman EM, Racke MK, Raine CS. Multiple sclerosis - the plaque and its pathogenesis. N Engl J Med 2006 354 : 942 55.
13. Boxel-Dezaire AH, Hoff SC, van Oosten BW et al. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann Neurol 1999 45 : 695 703.
14. Christensen T, Dissing SP, Riemann H, Hansen HJ, Moller-Larsen A. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis. Lancet 1998 352 : 1033.
15. Garson JA, Tuke PW, Giraud P, Paranhos-Baccala G, Perron H. Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet 1998 351 : 33.
16. Simmons A. Herpesvirus and multiple sclerosis. Herpes 2001 8 : 60 3.
17. Lu CZ, Jensen MA, Arnason BGW. Interferon [gamma]- and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 1993 46 : 123 8.
18. Beebe AM, Cua DJ, de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 2002 13 : 403 12.
19. Byrnes AA, McArthur JC, Karp CL. Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production. Ann Neurol 2002 51 : 165 74.
20. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13 : 227 31.
21. Soldan SS, Leist TP, Juhng KN, McFarland HF, Jacobson S. Increased lymphoproliferative response to human herpesvirus type 6A variant in multiple sclerosis patients. Ann Neurol 2000 47 : 306 13.
22. Munch M, Moller-Larsen A, Christensen T, Morling N, Hansen HJ, Haahr S. B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus. Mult Scler 1995 1 : 78 81.
23. Christensen T, Jensen AW, Munch M et al. Characterization of retroviruses from patients with multiple sclerosis. Acta Neurol Scand Suppl 1997 169 : 49 58.
24. Christensen T, Tonjes RR, zur MJ, Boller K, Moller-Larsen A. Reverse transcriptase activity and particle production in B lymphoblastoid cell lines established from lymphocytes of patients with multiple sclerosis. AIDS Res Hum Retroviruses 1999 15 : 285 91.
25. Lower R, Lower J, Kurth R. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. PNAS 1996 93 : 5177 84.
26. Mager DL. Human endogenous retroviruses and pathogenicity: genomic considerations. Trends Microbiol 1999 7 : 431.
27. Christensen T. Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses. Rev Med Virol 2005 15 : 179 211.
28. Nellaker C, Yao Y, Jones-Brando L, Mallet F, Yolken RH, Karlsson H. Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology 2006 3 : 44.
29. Ruprecht K, Obojes K, Wengel V et al. Regulation of human endogenous retrovirus W protein expression by herpes simplex virus type 1: implications for multiple sclerosis. J Neurovirol 2006 12 : 65 71.
30. Kwun HJ, Han HJ, Lee WJ, Kim HS, Jang KL. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res 2002 86 : 93 100.
31. Lee WJ, Kwun HJ, Kim HS, Jang KL. Activation of the human endogenous retrovirus W long terminal repeat by herpes simplex virus type 1 immediate early protein. Mol Cells 2003 15 : 75 80.
32. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity 2001 15 : 579 89.
33. Brudek T, Luhdorf P, Christensen T, Hansen HJ, Moller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J Neuroimmunol 2007 187 : 147 55.
34. Palu G, Benetti L, Calistri A. Molecular basis of the interactions between herpes simplex viruses and HIV-1. Herpes 2001 8 : 50 5.
35. Serra C, Mameli G, Arru G, Sotgiu S, Rosati G, Dolei A. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: implications for MS pathogenesis. J Neurovirol 2003 9 : 637 43.
36. de PN, Alkabbani H, Heidmann T. The long terminal repeats of the HERV-H human endogenous retrovirus contain binding sites for transcriptional regulation by the Myb protein. J Gen Virol 1999 80 (Pt 4 841 5.
37. Schon U, Seifarth W, Baust C, Hohenadl C, Erfle V, Leib-Mosch C. Cell type-specific expression and promoter activity of human endogenous retroviral long terminal repeats. Virology 2001 279 : 280 91.
38. Nelson DT, Goodchild NL, Mager DL. Gain of Sp1 sites and loss of repressor sequences associated with a young, transcriptionally active subset of HERV-H endogenous long terminal repeats. Virology 1996 220 : 213 8.
39. Lee WJ, Kwun HJ, Jang KL. Analysis of transcriptional regulatory sequences in the human endogenous retrovirus W long terminal repeat. J Gen Virol 2003 84 : 2229 35.
40. Hirsch RL, Panitch HS, Johnson KP. Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferon in vitro. J Clin Immunol 1985 5 : 386 9.
41. Lassmann H, Bruck W, Lucchinetti C. Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. Trends Mol Med 2001 7 : 115 21.
42. Lassmann H, Ransohoff RM. The CD4-Th1 model for multiple sclerosis: a critical [correction of crucial] re-appraisal. Trends Immunol 2004 25 : 132 7.
43. Merrill JE. Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome. J Immunother 1992 12 : 167 70.
44. Panitch HSM, Hirsch RLP, Schindler JP, Johnson KPM. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987 37 : 1097 102.
45. Panitch H, Haley A, Hirsch R, Johnson K. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987 329 : 893 5.
46. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992 13 : 198 200.
47. Musette P, Benveniste O, Lim A et al. The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis. Res Immunol 1996 147 : 435 41.
48. Salmaggi A, Dufour A, Eoli M et al. Low serum interleukin-10 levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol 1996 243 : 13 7.
49. Rieckmann P, Albrecht M, Kitze B et al. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994 44 : 1523 6.
50. Ozenci V, Kouwenhoven M, Huang YM et al. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-beta-1b treatment. Scand J Immunol 1999 49 : 554 61.
51. Ersoy E, Kus CN, Sener U, Coker I, Zorlu Y. The effects of interferon-beta on interleukin-10 in multiple sclerosis patients. Eur J Neurol 2005 12 : 208 11.